BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $111 at Credit Suisse
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $67.36 -1.71%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $111.00 (from $107.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
